SEC EDGAR filings, ownership reports, and insider transactions for Bain Capital Life Sciences Investors II, LLC.
Recent SEC filings for Bain Capital Life Sciences Investors II, LLC including 13F-NT, N-PX, 4 and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 17 Feb 2026 | 31 Dec 2025 | 028-20816 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Nov 2025 | 30 Sep 2025 | 028-20816 | |
| N-PX | Open N-PX document | View SEC filing for N-PX | 29 Aug 2025 | 30 Jun 2025 | 028-20816 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Aug 2025 | 30 Jun 2025 | 028-20816 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 May 2025 | 31 Mar 2025 | 028-20816 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 21 Feb 2025 | 19 Feb 2025 | 001-38360 |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Feb 2025 | 31 Dec 2024 | 028-20816 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 Dec 2024 | 13 Dec 2024 | 001-41562 |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Nov 2024 | 30 Sep 2024 | 028-20816 | |
| N-PX | Open N-PX document | View SEC filing for N-PX | 30 Aug 2024 | 30 Jun 2024 | 028-20816 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 12 Aug 2024 | 30 Jun 2024 | 028-20816 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 May 2024 | 31 Mar 2024 | 028-20816 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 13 Feb 2024 | 31 Dec 2023 | 028-20816 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 12 Jan 2024 | 11 Jan 2024 | 001-38360 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 29 Dec 2023 | 29 Dec 2023 | 001-41562 |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Nov 2023 | 30 Sep 2023 | 028-20816 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Aug 2023 | 30 Jun 2023 | 028-20816 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 16 May 2023 | 31 Mar 2023 | 028-20816 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Feb 2023 | 31 Dec 2022 | 028-20816 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 05 Dec 2022 | 02 Dec 2022 | 001-38360 |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Nov 2022 | 30 Sep 2022 | 028-20816 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Aug 2022 | 30 Jun 2022 | 028-20816 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 16 May 2022 | 31 Mar 2022 | 028-20816 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Feb 2022 | 31 Dec 2021 | 028-20816 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Dec 2021 | 08 Dec 2021 | 001-40925 |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Nov 2021 | 30 Sep 2021 | 028-20816 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 05 Nov 2021 | 26 Oct 2021 | 001-40925 |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 16 Aug 2021 | 30 Jun 2021 | 028-20816 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 17 May 2021 | 31 Mar 2021 | 028-20816 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 16 Feb 2021 | 31 Dec 2020 | 028-20816 |
Bain Capital Life Sciences Investors II, LLC files with the SEC under CIK 0001796155. This page aggregates EDGAR filings and related ownership activity.